ly4178256
ly4178256: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: ELI LILLY & Co (LLY)
Development Pipeline (1)
| Company | Phase |
|---|---|
| ELI LILLY & Co (LLY) | Phase 1 |
Clinical Trials (1)
A Phase 1, Placebo-Controlled, Single- and Multiple-Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4178256 in Healthy Participants
Frequently asked questions
Who is developing ly4178256?
ly4178256 is being developed by ELI LILLY & Co.
How many clinical trials involve ly4178256?
BioSniper tracks 1 clinical trial involving ly4178256.
Analyze ELI LILLY & Co & ly4178256 with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company